The use of generic DAAs for hepatitis C treatment, Freeman et al 2016

The use of generic DAAs for hepatitis C treatment, Freeman et al 2016

Download PDF

/ News

Share the Post

Related Posts

20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
Pricing of Indian generic sofosbuvir, 30th Jan,2016
Know the interactions between HIV and Hep C medicines
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
A two pager of what you need to know of Sofosbuvir
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015